Management of Biotech, Medtech & Pharma Ventures

Certificate of Advanced Studies (CAS)

In the increasingly complex world of therapeutic development, commercial, ethical and environmental concerns require companies to have clear insight into the specific processes of the pharma, biotech and medtech industries.

The core content in the seven modules (below) of this program gives managers the knowledge and tools they need to master the therapeutic development process from initial planning all the way to commercialization.

Participant Profile

This program is for technical professionals and managers who need clear insight into the specific processes of the biotech, medtech and pharma industries, including entrepreneurs and executives entering the pharma and medtech space for the first time.

Format

Each module consists of 3 full class days (Tuesday -Thursday), in person at the EPFL campus, along with pre-course and post-course work. Participants can choose to follow the whole program or select the modules they have an interest in.

A Certificate of Advanced Studies (CAS) is granted upon successful
completion of at least 5 modules

Strategic Alliances, Partnerships & Outsourcing

Jan 19-21, 2021

This module provides a framework for selecting ecosystem partners and for identifying and executing the right kind of partnership (alliance, joint-venture, outsourcing).

Managing Data for Value in Life Sciences

Feb 9-11, 2021

The medical devices, diagnostics, pharmaceuticals and biotechnology all depend on smart data management strategies. The Managing Data module shares successful approaches to the many critical data management opportunities & challenges and illustrates how to integrate them using real-life examples.

Intellectual Property Management in Life Sciences

Mar 2-4, 2021

International intellectual property protection strategies are essential to the success of therapeutic development enterprises. In this module we work through the strategic issues of intellectual property and how patents and trademarks are created, managed and enforced.

Clinical Trial Management & Regulatory Affairs

March 23-25, 2021

Our Clinical Trial module addresses how to manage clinical trials within the appropriate legislative frameworks. We review the regulations that govern medical devices & therapeutics, and cover good practices in managing clinical trials.

Marketing in Life Sciences

April 13-15, 2021

The key challenge in life sciences is growing the business in increasingly competitive global markets. In this module we examine the global market environment (customers, competitors, channels) and dive deep into the core methods for designing and implementing effective marketing strategies.

Current Good Manufacturing Practice (cGMP)

May 4-6, 2021

Manufacturing excellence contributes a growing share to an enterprise’s commercial success. In our cGMP module we address how planning, design, construction, qualification, validation and quality assurance impact medtech and biotech new process validation.

Project Management

June 1-3, 2021

Device and drug development is a long, complex, and demanding process. In this module we examine how a project management approach, with  thorough planning, identification of milestones, stakeholder management and the development of precise objectives all contribute to project success.

Tuition Fee

The fee for the CAS (5 modules) is CHF 11’500
Itemised fee for individual modules is outlined in the FAQs.

Admission Requirements

A University Degree & Fluency in English

Applications and Registrations

All applications for the CAS or individual modules should be done online. See the FAQs for required documents, then apply online:

Apply for the Certificate of Advanced Studies (5-7 modules)

Apply for one or more individual modules (1-4 modules)

Our most common questions are listed below, however feel free to get in touch at [email protected] if you have further questions.

COVID-19 Notice
The program is fully operational and is ready to adapt it’s delivery method as needed, in line with the directives set by EPFL. We are continuing to accept and process applications in our normal, timely manner. For any specific questions regarding the mode of delivery of classes in view of the Covid-19 situation, please contact us at [email protected]

FAQs

1 Module
CHF 2’450
2 Modules
CHF 4’800
3 Modules
CHF 7’150
4 Modules
CHF 9’500
5 Modules (minimum to obtain the CAS)
CHF 11’500
6 Modules
CHF 13’400
7 Modules
CHF 14’900

Although it is possible to take the CAS over two years, the progressive pricing as stated above is only applicable if the full amount is paid in the first year, by June 30th

A minimum of 5 modules must be successfully completed in order to obtain the CAS. 

  • Each module consists of 3 days of live classes
  • These are consecutive Tuesday, Wednesday and Thursday
  • Class days start at 9h15 and finish at 17h45
  • Each module includes pre- and post-course work

A University Degree & Fluency in English

Follow the online application link below. You will need:

  • Curriculum Vitae
  • Copy & transcript for each degree
  • A scan of your passport
  • One passport photo (minimum 300 dpi .jpg file)

Online application:

Applications are taken on a rolling basis; it is advisable to apply at least 15 days prior to the first module you’d like to attend.

You can start the CAS program from any module, and finish the remainder of the modules the following year.

Yes. You will receive a Letter of Attendance for each completed module. You need to successfully complete 5 modules to gain a CAS.

What our participants say

Irina Kruzhkova

“I would like to thank the organisers of the CAS in Management of BioTech, Medtech and Pharma Ventures for this unforgettable experience and knowledge I gained in the course of the programme. Outstanding speakers, very well organised lectures, with thoroughly planned time for theory and case studies. Can highly recommend to my colleagues working in various sectors of the industry.” – Irina Kruzhkova, Clinical Trial Manager, Clinical R&D Haematology, Octapharma AG (2020 Graduate)

.

Bernard Fourie

“The CAS in Management of Biotech, Medtech & Pharma Ventures provides a well-structured, modular platform from which to gain deep knowledge of and practical insights into the industry. High-calibre students and industry professionals make for an engaging and impactful learning experience”  – Bernard Fourie, Senior Director R&D, Global Head of Finance & Controlling. (2020 Graduate)

Christel Dendas

“The program fully met my expectations and offered me valuable insights. I particularly appreciated the relevance of the course content and the choice of the teachers, all highly experienced from the industry. What am I taking away? A better understanding of my clients’ needs, a clarified strategic positioning of my business unit with a new perspective on tomorrow’s market, inspiration to sharpen some of our internal processes critical to winning in the industry and new network.  Strongly recommended!” – Christel Dendas, President, Health and Skin Care at Jacob Holm. (2020 Graduate)